Sign In
Buy SNDL
Sundial Growers Earnings Calls
| Release date | Apr 29, 2026 |
| EPS estimate | -$0.0300 |
| EPS actual | -$0.0300 |
| Revenue estimate | 151.195M |
| Revenue actual | 140.841M |
| Revenue Surprise | -6.85% |
| Release date | Mar 12, 2026 |
| EPS estimate | $0.0100 |
| EPS actual | $0.0300 |
| EPS Surprise | 200.00% |
| Revenue estimate | 187.857M |
| Revenue actual | 183.87M |
| Revenue Surprise | -2.12% |
| Release date | Nov 04, 2025 |
| EPS estimate | -$0.0004 |
| EPS actual | -$0.0400 |
| EPS Surprise | -11,011.11% |
| Revenue estimate | 257.974M |
| Revenue actual | 175.1M |
| Revenue Surprise | -32.12% |
| Release date | Jul 31, 2025 |
| EPS estimate | -$0.0400 |
| EPS actual | $0.0100 |
| EPS Surprise | 125.00% |
| Revenue estimate | 242.976M |
| Revenue actual | 179.656M |
| Revenue Surprise | -26.06% |
Last 4 Quarters for Sundial Growers
Below you can see how SNDL performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 31, 2025 |
| Price on release | $1.72 |
| EPS estimate | -$0.0400 |
| EPS actual | $0.0100 |
| EPS surprise | 125.00% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $1.52 |
| Jul 28, 2025 | $1.50 |
| Jul 29, 2025 | $1.46 |
| Jul 30, 2025 | $1.44 |
| Jul 31, 2025 | $1.72 |
| Aug 01, 2025 | $1.65 |
| Aug 04, 2025 | $1.64 |
| Aug 05, 2025 | $1.66 |
| Aug 06, 2025 | $1.69 |
| 4 days before | 13.53% |
| 4 days after | -1.74% |
| On release day | -4.07% |
| Change in period | 11.55% |
| Release date | Nov 04, 2025 |
| Price on release | $1.86 |
| EPS estimate | -$0.0004 |
| EPS actual | -$0.0400 |
| EPS surprise | -11,011.11% |
| Date | Price |
|---|---|
| Oct 29, 2025 | $2.16 |
| Oct 30, 2025 | $2.13 |
| Oct 31, 2025 | $2.15 |
| Nov 03, 2025 | $2.19 |
| Nov 04, 2025 | $1.86 |
| Nov 05, 2025 | $1.85 |
| Nov 06, 2025 | $1.76 |
| Nov 07, 2025 | $1.78 |
| Nov 10, 2025 | $1.87 |
| 4 days before | -13.89% |
| 4 days after | 0.538% |
| On release day | -0.538% |
| Change in period | -13.43% |
| Release date | Mar 12, 2026 |
| Price on release | $1.56 |
| EPS estimate | $0.0100 |
| EPS actual | $0.0300 |
| EPS surprise | 200.00% |
| Date | Price |
|---|---|
| Mar 06, 2026 | $1.51 |
| Mar 09, 2026 | $1.54 |
| Mar 10, 2026 | $1.56 |
| Mar 11, 2026 | $1.54 |
| Mar 12, 2026 | $1.56 |
| Mar 13, 2026 | $1.51 |
| Mar 16, 2026 | $1.44 |
| Mar 17, 2026 | $1.44 |
| Mar 18, 2026 | $1.38 |
| 4 days before | 3.31% |
| 4 days after | -11.54% |
| On release day | -3.21% |
| Change in period | -8.61% |
| Release date | Apr 29, 2026 |
| Price on release | $1.32 |
| EPS estimate | -$0.0300 |
| EPS actual | -$0.0300 |
| Date | Price |
|---|---|
| Apr 23, 2026 | $1.53 |
| Apr 24, 2026 | $1.51 |
| Apr 27, 2026 | $1.51 |
| Apr 28, 2026 | $1.47 |
| Apr 29, 2026 | $1.32 |
| Apr 30, 2026 | $1.36 |
| May 01, 2026 | $1.41 |
| May 04, 2026 | $1.42 |
| May 05, 2026 | $1.43 |
| 4 days before | -14.05% |
| 4 days after | 8.75% |
| On release day | 3.42% |
| Change in period | -6.54% |
Sundial Growers Earnings Call Transcript Summary of Q1 2026
SNDL reported Q1 2026 results with net revenue of $196M, a 4.4% YoY decline driven by softness in liquor and cannabis operations. Retail margins improved (liquor +20 bps, cannabis retail +100 bps) through pricing, promotion efficiency and mix, but consolidated gross margin fell 70 bps due to cannabis operations. Cannabis operations saw a 14% revenue decline and ~700 bps margin compression from destocking, production under-absorption, Jeeter ramp inefficiencies and one-time inventory/asset adjustments. Management implemented profit-enhancement initiatives expected to generate >$20M of incremental operating income for the remainder of 2026 and repurchased 4.5M shares in Q1 under the board-approved buyback. Free cash flow was negative $7.6M reflecting seasonality, higher inventory (partly for Jeeter) and increased CapEx/lease timing; cash on hand was $213.4M (new IFRS presentation excludes cash-in-transit). Management expects revenue improvement in H2 2026 as initiatives take hold and comparisons ease; U.S. regulatory rescheduling (DEA action moving certain medical cannabis toward Schedule III) is seen as constructive for SNDL's U.S. credit exposure (SunStream/Parallel) and may improve restructuring prospects. Key near-term priorities: execute Jeeter rollout in Canada, continue retail discipline and margin expansion, complete SunStream/Parallel restructuring steps before pursuing larger U.S. investments, and continue share repurchases while the stock trades below internal valuation.
